Sandeep Datta, MD
Interventional Pain Medicine · Macon, GANPI 1477546166
Payments from drug & device makers
Across 494 payments — averaging $56.18 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Boston Scientific$12K
- Medtronic$7K
- Surgentec$4K
- Curonix LLC$1K
- Nevro Corp.$1K
- SPR Therapeutics, Inc$407
- plus $3K from 24 others
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Boston Scientific | 207 | $11,653 |
| Medtronic(2 entities) | 106 | $7,097 |
| Surgentec | 1 | $3,686 |
| Curonix LLC | 16 | $1,223 |
| Nevro Corp. | 26 | $1,006 |
| SPR Therapeutics, Inc | 5 | $407 |
| Collegium Pharmaceutical, Inc. | 23 | $390 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 23 | $384 |
| Scilex Pharmaceuticals Inc. | 21 | $359 |
| Nalu Medical, Inc. | 12 | $330 |
| Biodelivery Sciences International, Inc. | 7 | $308 |
| Vertos Medical, Inc. | 3 | $215 |
| Daiichi Sankyo Inc. | 10 | $111 |
| Pfizer | 7 | $105 |
| Abbott | 5 | $90 |
| Globus Medical | 3 | $54 |
| Forte Bio-pharma LLC | 3 | $49 |
| Relievant Medsystems, Inc. | 2 | $41 |
| Bioventus LLC | 1 | $36 |
| IBSA Pharma Inc. | 2 | $33 |
| Arbor Pharmaceuticals, Inc. | 2 | $30 |
| Redhill Biopharma Inc. | 1 | $23 |
| Flowonix Medical Incorporated | 1 | $23 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $17 |
| Vertex | 1 | $16 |
| Amgen | 1 | $16 |
| Lilly USA, LLC | 1 | $14 |
| Shionogi Inc | 1 | $13 |
| Pernix Therapeutics Holdings, Inc. | 1 | $13 |
| Assertio Therapeutics, Inc. | 1 | $12 |
How this compares
$27,753 in reported general payments places this provider in the 85th percentile of 129 interventional pain medicine providers in Georgia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other interventional pain medicine in Macon
- Stephen TaforMacon$16K
- Margaret BoltjaMacon$7K
- Jeremy PrineMacon$7K
- Marvin TarkMarietta$3.6M
- Jordan TateJasper$764K
- Emmanuel GageBrunswick$648K
- Christopher BovinetBrunswick$356K
- D Terrence FosterStockbridge$305K
- David RosenfeldCovington$287K
- Nathan NeufeldNewnan$171K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.